Table of Content

1 Industrial Chain Overview

• 1.1 Cancer Tubulin Inhibitors Industry
  • 1.1.1 Overview
  • 1.1.2 Characteristics of Cancer Tubulin Inhibitors
• 1.2 Upstream
  • 1.2.1 Major Materials
  • 1.2.2 Manufacturing Overview
• 1.3 Product List By Type
  • 1.3.1 Docetaxel
  • 1.3.2 Trastuzumab Emtansine
  • 1.3.3 Abraxane
  • 1.3.4 Brentuximab Vedotin
  • 1.3.5 Cabazitaxel
• 1.4 End-Use List
  • 1.4.1 Demand in Non Small Cell Lung Cancer
  • 1.4.2 Demand in Prostate Cancer
  • 1.4.3 Demand in Breast Cancer
  • 1.4.4 Demand in Colorectal Cancer
  • 1.4.5 Demand in Ovarian Cancer
• 1.5 Global Market Overview
  • 1.5.1 Global Market Size and Forecast, 2015-2025
  • 1.5.2 Global Market Size and Forecast by Geography with CAGR, 2015-2025
  • 1.5.3 Global Market Size and Forecast by Product Type with CAGR, 2015-2025
  • 1.5.4 Global Market Size and Forecast by End-Use with CAGR, 2015-2025

2 Global Production & Consumption by Geography

• 2.1 Global Production & Consumption
  • 2.1.1 Global Production
  • 2.1.2 Global Consumption
• 2.2 Geographic Production & Consumption
  • 2.2.1 Production
    • 2.2.1.1 Asia-Pacific
    • 2.2.1.2 North America
    • 2.2.1.3 South America
    • 2.2.1.4 Europe
    • 2.2.1.5 Middle East & Africa
  • 2.2.2 Consumption
    • 2.2.2.1 Asia-Pacific
    • 2.2.2.2 North America
    • 2.2.2.3 South America
    • 2.2.2.4 Europe
    • 2.2.2.5 Middle East & Africa

  3 Major Manufacturers Introduction

  • 3.1 Manufacturers Overview
  • 3.2 Manufacturers List
    • 3.2.1 Abraxis Biosciences Overview
      • 3.2.1.1 Product Specifications
      • 3.2.1.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.1.3 Recent Developments
      • 3.2.1.4 Future Strategic Planning
    • 3.2.2 Agensys Overview
      • 3.2.2.1 Product Specifications
      • 3.2.2.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.2.3 Recent Developments
      • 3.2.2.4 Future Strategic Planning
    • 3.2.3 Amgen Overview
      • 3.2.3.1 Product Specifications
      • 3.2.3.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.3.3 Recent Developments
      • 3.2.3.4 Future Strategic Planning
    • 3.2.4 Celgene Overview
      • 3.2.4.1 Product Specifications
      • 3.2.4.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.4.3 Recent Developments
      • 3.2.4.4 Future Strategic Planning
    • 3.2.5 Eagle Pharmaceuticals Overview
      • 3.2.5.1 Product Specifications
      • 3.2.5.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.5.3 Recent Developments
      • 3.2.5.4 Future Strategic Planning
    • 3.2.6 Endocyte Overview
      • 3.2.6.1 Product Specifications
      • 3.2.6.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.6.3 Recent Developments
      • 3.2.6.4 Future Strategic Planning
    • 3.2.7 Genentech Overview
      • 3.2.7.1 Product Specifications
      • 3.2.7.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.7.3 Recent Developments
      • 3.2.7.4 Future Strategic Planning
    • 3.2.8 Immunogen Overview
      • 3.2.8.1 Product Specifications
      • 3.2.8.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.8.3 Recent Developments
      • 3.2.8.4 Future Strategic Planning
    • 3.2.9 Modra Pharmaceuticals Overview
      • 3.2.9.1 Product Specifications
      • 3.2.9.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.9.3 Recent Developments
      • 3.2.9.4 Future Strategic Planning
    • 3.2.10 Pierre Fabre Overview
      • 3.2.10.1 Product Specifications
      • 3.2.10.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.10.3 Recent Developments
      • 3.2.10.4 Future Strategic Planning
    • 3.2.11 Roche Overview
      • 3.2.11.1 Product Specifications
      • 3.2.11.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.11.3 Recent Developments
      • 3.2.11.4 Future Strategic Planning
    • 3.2.12 Sanofi-Aventis Overview
      • 3.2.12.1 Product Specifications
      • 3.2.12.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.12.3 Recent Developments
      • 3.2.12.4 Future Strategic Planning
    • 3.2.13 Seattle Genetics Overview
      • 3.2.13.1 Product Specifications
      • 3.2.13.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.13.3 Recent Developments
      • 3.2.13.4 Future Strategic Planning
    • 3.2.14 Tocris Bioscience Overview
      • 3.2.14.1 Product Specifications
      • 3.2.14.2 Business Data (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Margin)
      • 3.2.14.3 Recent Developments
      • 3.2.14.4 Future Strategic Planning

    4 Market Competition Pattern

    • 4.1 Market Size and Sketch
    • 4.2 Company Market Share
      • 4.2.1 Global Production by Major Manufacturers
      • 4.2.2 Market Concentration Analysis
    • 4.3 Market News and Trend
      • 4.3.1 Merger & Acquisition
      • 4.3.2 New Product Launch

    5 Product Type Segment

    • 5.1 Global Overview by Product Type Segment
    • 5.2 Segment Subdivision by Product Type
      • 5.2.1 Market in Docetaxel
        • 5.2.1.1 Market Size
        • 5.2.1.2 Situation & Development
      • 5.2.2 Market in Trastuzumab Emtansine
        • 5.2.2.1 Market Size
        • 5.2.2.2 Situation & Development
      • 5.2.3 Market in Abraxane
        • 5.2.3.1 Market Size
        • 5.2.3.2 Situation & Development
      • 5.2.4 Market in Brentuximab Vedotin
        • 5.2.4.1 Market Size
        • 5.2.4.2 Situation & Development
      • 5.2.5 Market in Cabazitaxel
        • 5.2.5.1 Market Size
        • 5.2.5.2 Situation & Development

      6 End-Use Segment

      • 6.1 Global Overview by End-Use Segment
      • 6.2 Segment Subdivision
        • 6.2.1 Market in Non Small Cell Lung Cancer
          • 6.2.1.1 Market Size
          • 6.2.1.2 Situation & Development
        • 6.2.2 Market in Prostate Cancer
          • 6.2.2.1 Market Size
          • 6.2.2.2 Situation & Development
        • 6.2.3 Market in Breast Cancer
          • 6.2.3.1 Market Size
          • 6.2.3.2 Situation & Development
        • 6.2.4 Market in Colorectal Cancer
          • 6.2.4.1 Market Size
          • 6.2.4.2 Situation & Development
        • 6.2.5 Market in Ovarian Cancer
          • 6.2.5.1 Market Size
          • 6.2.5.2 Situation & Development

        7 Market Forecast & Trend

        • 7.1 Regional Forecast
        • 7.2 Consumption Forecast
          • 7.2.1 Product Type Forecast
          • 7.2.2 End-Use Forecast
        • 7.3 Investment Trend
        • 7.4 Consumption Trend

        8 Price & Channel

        • 8.1 Price and Cost
          • 8.1.1 Price
          • 8.1.2 Cost
        • 8.2 Channel Segment

        9 Market Drivers & Investment Environment

        • 9.1 Market Drivers
        • 9.2 Investment Environment

        10 Research Conclusion

        List of Tables

        Table Global Market Size and Forecast by Geography with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by Type with Growth Rate, 2015-2025

        Table Global Market Size and Forecast by End-Use with Growth Rate, 2015-2025

        Table Global Production Volume Status and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Production Amount Status and Growth Rate by Geography, 2015-2018, in Million USD

        Table Global Market Volume and Growth Rate by Geography, 2015-2018, in Volume

        Table Global Market Amount and Growth Rate by Geography, 2015-2018, in Million USD

        Table Asia-Pacific Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table North America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table South America Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table South America Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Production Volume Status and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Production Amount Status and Growth Rate by Region, 2015-2018, in Million USD

        Table Asia-Pacific Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Asia-Pacific Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table North America Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table North America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table South America Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Europe Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Europe Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Middle East & Africa Market Volume and Growth Rate by Region, 2015-2018, in Volume

        Table Middle East & Africa Market Amount and Growth Rate by Region, 2015-2018, in Million USD

        Table Major Manufacturers Headquarters and Contact Information

        Table Major Manufacturers Capacity List in 2018

        Table Abraxis Biosciences Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Abraxis Biosciences (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Agensys Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Agensys (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Amgen Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Amgen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Celgene Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Celgene (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Eagle Pharmaceuticals Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Eagle Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Endocyte Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Endocyte (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Genentech Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Genentech (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Immunogen Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Immunogen (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Modra Pharmaceuticals Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Modra Pharmaceuticals (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Pierre Fabre Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Pierre Fabre (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Roche Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Roche (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Sanofi-Aventis Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Sanofi-Aventis (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Seattle Genetics Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Seattle Genetics (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Tocris Bioscience Overview List

        Table Cancer Tubulin Inhibitors Business Operation of Tocris Bioscience (Production Volume (Volume), Production Amount (Million USD), Price, Cost, Gross Margin)

        Table Global Production Volume List by Manufacturers, 2015-2018, in Volume

        Table Global Production Volume Share List by Manufacturers, 2015-2018, in Volume

        Table Global Production Amount List by Manufacturers, 2015-2018, in Million USD

        Table Global Production Amount Share List by Manufacturers, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by Product Type Segment 2015-2018, in Volume

        Table Global Market Status and Growth Rate by End-Use Segment, 2015-2018, in Million USD

        Table Global Market Status and Growth Rate by End-Use Segment 2015-2018, in Volume

        Table Global Market Forecast by Region Segment 2019-2025, in Million USD

        Table Global Market Forecast by Region Segment 2019-2025, in Volume

        Table Global Market Amount by Product Type Segment 2019-2025, in Million USD

        Table Global Market Volume by Product Type Segment 2019-2025, in Volume

        Table Global Market Amount by End-Use Segment 2019-2025, in Million USD

        Table Global Market Volume by End-Use Segment 2019-2025, in Volume

        List of Figures

        Figure Cancer Tubulin Inhibitors Picture List

        Figure Global Market Size and Forecast with Growth Rate, 2015-2025

        Figure Global Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Global Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Global Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure North America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure North America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure South America Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure South America Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Europe Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Europe Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Production Volume Status and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Production Amount Status and Growth Rate, 2015-2018, in Million USD

        Figure Asia-Pacific Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Asia-Pacific Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure North America Market Volume and Growth Rate, 2015-2018, in Volume

        Figure North America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure South America Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Europe Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Europe Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Middle East & Africa Market Volume and Growth Rate, 2015-2018, in Volume

        Figure Middle East & Africa Market Amount and Growth Rate, 2015-2018, in Million USD

        Figure Global Production Volume Share by Manufacturers in 2019, in Volume

        Figure Global Production Amount Share by Manufacturers in 2019, in Million USD

        Figure Global Market Amount and Growth Rate in Docetaxel, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Docetaxel, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Trastuzumab Emtansine, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Trastuzumab Emtansine, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Abraxane, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Abraxane, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Brentuximab Vedotin, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Brentuximab Vedotin, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Cabazitaxel, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Cabazitaxel, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Non Small Cell Lung Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Non Small Cell Lung Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Prostate Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Prostate Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Breast Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Breast Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Colorectal Cancer, 2015-2018, in Volume

        Figure Global Market Amount and Growth Rate in Ovarian Cancer, 2015-2018, in USD Million

        Figure Global Market Amount and Growth Rate in Ovarian Cancer, 2015-2018, in Volume

According to 99Strategy, the Global Cancer Tubulin Inhibitors Market is estimated to reach xxx million USD in 2019 and projected to grow at the CAGR of xx% during the 2020-2025. The report analyses the global Cancer Tubulin Inhibitors market, the market size and growth, as well as the major market participants.
The analysis includes market size, upstream situation, market segmentation, market segmentation, price & cost and industry environment. In addition, the report outlines the factors driving industry growth and the description of market channels.The report begins from overview of industrial chain structure, and describes the upstream. Besides, the report analyses market size and forecast in different geographies, type and end-use segment, in addition, the report introduces market competition overview among the major companies and companies profiles, besides, market price and channel features are covered in the report.
Key Regions
Asia Pacific
North America
Europe
South America
Middle East & Africa
Key Companies
Abraxis Biosciences
Agensys
Amgen
Celgene
Eagle Pharmaceuticals
Endocyte
Genentech
Immunogen
Modra Pharmaceuticals
Pierre Fabre
Roche
Sanofi-Aventis
Seattle Genetics
Tocris Bioscience
Key Product Type
Docetaxel
Trastuzumab Emtansine
Abraxane
Brentuximab Vedotin
Cabazitaxel
Market by Application
Non Small Cell Lung Cancer
Prostate Cancer
Breast Cancer
Colorectal Cancer
Ovarian Cancer
Main Aspects covered in the Report
Overview of the Cancer Tubulin Inhibitors market including production, consumption, status & forecast and market growth
2015-2018 historical data and 2019-2025 market forecast
Geographical analysis including major countries
Overview the product type market including development
Overview the end-user market including development